Identification of (1H)-pyrroles as histone deacetylase inhibitors with antitumoral activity

Aizpea Zubia; Santiago Ropero; Dorleta Otaegui; Esteban Ballestar; Mario F. Fraga; Manuel Boix-Chornet; María Berdasco; Alfredo Martı́nez; Llorenç Coll-Mulet; Joan Gil; Fernando P. Cossío; Manel Esteller

doi:10.1038/onc.2008.501

Related publications

Article2004

Histone deacetylase inhibitors: Understanding a new wave of anticancer agents

Ana Villar‐Garea, Manel Esteller

Article2013

The role of histone deacetylase inhibitors in patients with relapsed/refractory multiple myeloma

Roman Hájek, David S. Siegel, Robert Z. Orlowski, Heinz Ludwig, Antonio Palumbo, Meletios A Dimopoulos

Article2005

Decreased Histone Deacetylase Activity in Chronic Obstructive Pulmonary Disease

Kazuhiro Ito, Misako Ito, W. Mark Elliott, Borja G. Cosío, Gaetano Caramori, Onn Min Kon, Adam Barczyk, Shizu Hayashi, Ian M. Adcock, James C. Hogg, Peter J Barnes

Article2004

Theophylline Restores Histone Deacetylase Activity and Steroid Responses in COPD Macrophages

Borja G. Cosío, Loukia Tsaprouni, Kazuhiro Ito, Elen Jazrawi, Ian M. Adcock, Peter J Barnes

Article2015

Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD

Joseph Footitt, Patrick Mallia, Andrew Durham, Wanxing Eugene Ho, Maria‐Belen Trujillo‐Torralbo, Aurica G. Telcian, Ajerico del Rosario, Cheng Chang, Hong Yong Peh, Tatiana Kebadze, Julia Aniscenko, L Stanciu, Sarah Essilfie-Quaye, Kazuhiro Ito, Peter J Barnes, Sarah Elkin, Onn Min Kon, W.S. Fred Wong, Ian M. Adcock, Sebastian L. Johnston